Form 8-K - Current report:
SEC Accession No. 0001213900-25-094711
Filing Date
2025-10-01
Accepted
2025-10-01 16:30:26
Documents
20
Period of Report
2025-09-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0259464-8k_silo.htm   iXBRL 8-K 39391
2 FORM OF WARRANT ea025946401ex4-1_silo.htm EX-4.1 94008
3 FORM OF PLACEMENT AGENT WARRANT ea025946401ex4-2_silo.htm EX-4.2 95379
4 OPINION OF SHEPPARD, MULLIN, RICHTER & HAMPTON LLP ea025946401ex5-1_silo.htm EX-5.1 12999
5 FORM OF SECURITIES PURCHASE AGREEMENT ea025946401ex10-1_silo.htm EX-10.1 241049
6 PRESS RELEASE OF SILO PHARMA, INC. DATED SEPTEMBER 30, 2025 ea025946401ex99-1_silo.htm EX-99.1 10334
7 PRESS RELEASE OF SILO PHARMA, INC. DATED OCTOBER 1, 2025 ea025946401ex99-2_silo.htm EX-99.2 9425
8 GRAPHIC ex5-1_001.jpg GRAPHIC 10169
9 GRAPHIC ex99-1_001.jpg GRAPHIC 2354
  Complete submission text file 0001213900-25-094711.txt   812053

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE silo-20250929.xsd EX-101.SCH 3020
11 XBRL LABEL FILE silo-20250929_lab.xml EX-101.LAB 34239
12 XBRL PRESENTATION FILE silo-20250929_pre.xml EX-101.PRE 22362
22 EXTRACTED XBRL INSTANCE DOCUMENT ea0259464-8k_silo_htm.xml XML 3566
Mailing Address 677 N. WASHINGTON BLVD SARASOTA FL 34236
Business Address 677 N. WASHINGTON BLVD SARASOTA FL 34236 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

EIN.: 462137136 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41512 | Film No.: 251365029
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)